Study of aflatoxicosis reduction: effect of Alchornea cordifolia on biomarkers in an aflatoxin B1 exposed rats

References

• Adjanohoun, E.J., 1994. Fiche espèce: Alchornea cordifolia. Bull Med Trad Pharm, 8, 203–213.
   Google Scholar
• Adjanohoun, E. J., and Aké, A. L., 1979. Contribution aur ecensementdesplantes médicinalesen Côte d'ivoire. Abidjan: Edition CRESS, 41–218.
   Google Scholar
• Ajali, U., 2000. Antibacterial activity of Alchornea cordifolia stem bark. Fitoterapia, 71, 436–438.
   PubMed Web of Science ®Google Scholar
• Banzouzi, J.T., et al., 2002. In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid. Journal of Ethnopharmacology, 81, 399–401.
   PubMed Web of Science ®Google Scholar
• Campbell, T.C., et al., 1970. Aflatoxin M1 in human urine. Nature, 227, 403–404.
   PubMed Web of Science ®Google Scholar
• Chizzola, R., Michitsch, H., and Franz, C., 2008. Antioxidative properties of Thymus vulgaris leaves: comparison of different extracts and essential oil chemotypes. Journal of Agricultural and Food Chemistry, 56, 6897–6904.
   PubMed Web of Science ®Google Scholar
• Ch'ih, J.J., et al., 1989. 2(3)-Tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes. Proceedings of the Society for Experimental Biology and Medicine, 192 (1), 35–42.
   PubMed Web of Science ®Google Scholar
• Chen, C., Pearson, A.M., and Gray, J.I., 1992. Effects of synthetic antioxidants (BHA, BHT and PG) on the mutagenicity of IQ-like compounds. Food Chemistry, 43, 177–183.
   Web of Science ®Google Scholar
• El-Nezami, H.S., et al., 2006. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. The American journal of clinical nutrition, 83, 1199–1203.
   PubMed Web of Science ®Google Scholar
• Essigmann, J.M., et al., 1977. Structural identification of the major DNA adduct formed by aflatoxin b1 in vitro. Proceedings of the National Academy of Sciences of the United States of America, 74, 1870–1874.
   PubMed Web of Science ®Google Scholar
• Essigmann, J.M., et al., 1982. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metabolism Reviews, 13 (4), 581–602.
   PubMed Web of Science ®Google Scholar
• EU Directive 2010/63/EU of the Europe an Parliament and of the Council of 22 September, 2010. The protection of animals used for scientific purposes, Official Journal of the European Union L276/33. [Document consulté sur le site: http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htmle 15 mars 2016]
   Google Scholar
• Hariri, E.B., Sallé, G., and Andary, C., 1991. Involvement of flavonoids in the resistance of two poplar cultivars to mistletoe (Viscum album L.). Protoplasma, 162 (1), 20–26.
   Web of Science ®Google Scholar
• Heim, K.E., Tagliaferro, A.R., and Bobilya, D.J., 2002. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. Journal of Nutritional Biochemistry, 13, 572–584.
   PubMed Web of Science ®Google Scholar
• IARC, 1993. Aflatoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 56, 245–395
   Google Scholar
• IARC, 2002. Aflatoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 62, 171–300.
   Google Scholar
• Ito, N., et al., 1983. Carcinogenicity of butylated hydroxyanisole in F344 rats. Journal of the National Cancer Institute, 70, 343–352.
   PubMed Web of Science ®Google Scholar
• Gan, L.S., et al., 1988. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B 1 intake and urinary excretion of aflatoxin M1. Carcinogenesis, 9, 1323–1325.
   PubMed Web of Science ®Google Scholar
• Giolo, M.P., et al., 2012. Aflatoxin M1 in the urine of non-carriers and chronic carriers of hepatitis B virus in Maringa, Brazil. Brazilian Journal of Pharmaceutical Sciences, 48, 3.
   Web of Science ®Google Scholar
• Kambu, K., et al., 1990. Antispasmodic activity of extracts proceeding of plant, antidiarrhoeic traditional preparations used in Kinshasa, Zaire. Annales Pharmaceutiques Françaises, 48, 200–208.
   PubMedGoogle Scholar
• Kouakou-Siransy, G., et al., 2010a. Effects of Alchornea cordifolia on elastase and superoxide anion produced by human neutrophils. Pharmaceutical Biology, 48 (2), 128–133.
   PubMed Web of Science ®Google Scholar
• Kouakou-Siransy, G., et al., 2010b. Oxygen species scavenger activities and phenolic contents of four West African plants. Food Chemistry, 118, 430–435.
   Web of Science ®Google Scholar
• Mavar-Manga, H., et al., 2008. Antiinflammatory compounds from leaves and root bark of Alchornea cordifolia (Schumach and Thonn.). Mull. Arg. Journal of Ethnopharmacology, 115 (1), 25–29.
   PubMed Web of Science ®Google Scholar
• Muanza, D.N., et al., 1994. Antibacterial and antifungal activities of nine medicinal plants from Zaire. International Journal of Pharmacognosy, 32, 337–345.
   Google Scholar
• Neeta, M., and Ramtej, J.V., 2007. Ameliorative effect of curcumin on aflatoxin-induced toxicity in DNA, RNA and protein in liver and kidney of mice. Acta Poloniae Pharmaceutica-Drug Research, 64 (6), 497–502.
   PubMedGoogle Scholar
• Osadebe, P., et al., 2012. Phytochemical analysis, hepatoprotective and antioxidant activity of Alchornea cordifolia methanol leaf extract on carbon tetrachloride-induced hepatic damage in rats. Asian Pacific Journal of Tropical Medicine, 5, 289–293.
   PubMed Web of Science ®Google Scholar
• Ogungbamila, F.O., and Samuelsson, G., 1990. Smooth muscle relaxing flavonoids from Alchornea cordifolia (leaves). Acta Pharmaceutica Nordica, 2, 421–422.
   PubMedGoogle Scholar
• Okeke, I.N., et al., 1999. Antimicrobial spectrum of Alchornea cordifolia leaf extract. Phytotherapy Research, 13, 67–69.
   PubMed Web of Science ®Google Scholar
• Qian, G., 2012. Integrative toxicological evaluation of aflatoxin B1 exposure in Fischer 344 rats and biomarker based exposure assessment of aflatoxin B1 in human populations. These of philosophy, University of Georgia, 265.
   Google Scholar
• Qian, G.S., et al., 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiology Biomarkers and Prevention, 3, 3–10.
   PubMed Web of Science ®Google Scholar
• Redzwan, S.M., et al., 2016. Effect of supplementation of fermented milk drink containing probiotic Lactobacillus casei Shirota on the concentrations of a?atoxin biomarkers among employees of Universiti Putra Malaysia: a randomised, double- blind, cross-over, placebo-con trolled study. British Journal of Nutrition, 115 (1), 39–54.
   PubMed Web of Science ®Google Scholar
• Roebuck, B.D., et al., 1991. Protection against aflatoxin Bi-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-l,2-dithiole-3-thione (Oltipraz): predictive role for short-term molecular dosimetry. Cancer Research, 51, 5501–5506.
   PubMed Web of Science ®Google Scholar
• Romero, A.C., et al., 2010. Occurrence of AFM1 in urine samples of a Brazilian population and association with food consumption. Food Control, 21 (4), 554–558.
   Web of Science ®Google Scholar
• Sabbioni, G., et al., 1987. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis, 8, 819–824.
   PubMed Web of Science ®Google Scholar
• Sass, D.C., et al., 2015. Synthesis and purification of the aflatoxin B1-lysine adduct. Toxin Reviews, 34, 53–59.
   Web of Science ®Google Scholar
• Scholl, P.F., and Groopman, J.D., 2004. Synthesis of 5,5,6,6-D4-l-lysine-aflatoxin B1 for use as a mass spectrometric internal standard. Journal of Labelled Compounds and Radiopharmaceuticals, 47, 807–815.
   Web of Science ®Google Scholar
• Sharma, S., tutzman, J.D., and Steele, V.E., 1994. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Research, 54 (22), 5848–5855.
   PubMed Web of Science ®Google Scholar
• Singleton, V.L., and Rossi, J.A., 1965. Colorimetry of total phenolics with phosphomolybdic?phosphotungstic acid reagents. American journal of enology and viticulture, 16, 144–158.
   Google Scholar
• Sujatha, N., Suryakala, S., and Rao, B.S., 2001. Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation. Journal of AOAC International, 84, 5.
   Web of Science ®Google Scholar
• Tona, L., et al., 2000. Antiamoebic and spasmolitic activities of extracts from some antidiarrhoeal traditional preparations used in Kinshasa, Congo. Phytomedicine, 7, 31–38.
   PubMed Web of Science ®Google Scholar
• Tona, L., et al., 1998. Antiamoebic and phytochemical screening of some Congolese medicinal plants. Journal of Ethnopharmacology, 61, 57–65.
   PubMed Web of Science ®Google Scholar
• Tran, A.V., 2013. Do BHA and BHT induce morphological changes and dna double-strand breaks in Schizosaccharomyces pombe?. Scripps Senior Rheses, 152.
   Google Scholar
• Tang, L., et al., 2007. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats. Toxicology and Applied Pharmacology, 219, 10–17.
   PubMed Web of Science ®Google Scholar
• Williams, G.M., and Iatropoulos, M.J., 1996. Inhibition of the hepatocarcinogenicity of aflatoxin B, in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Letters, 104, 49–53.
   PubMed Web of Science ®Google Scholar
• Wang, P., et al., 2008. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Additives and Contaminants, 25 (5), 622–634.
   Web of Science ®Google Scholar
• Wild, C.P., et al., 1992. Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma. The Gambia and Thailand: Toxicology Letters, 64 (65), 455–461.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.J., et al., 2012. Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. World Journal of Hepatology, 4, 169–175.
   PubMedGoogle Scholar